[Lung cancer screening: Update, news and perspectives].
Dépistage du cancer du poumon : mise au point, actualités et perspectives.
CT scan
Cancer du poumon
Dépistage
Lung cancer
Lung nodule
Nodule pulmonaire
Screening
Solitary pulmonary nodule
Tabagisme
Tobacco smoking
Tomodensitométrie
Journal
Bulletin du cancer
ISSN: 1769-6917
Titre abrégé: Bull Cancer
Pays: France
ID NLM: 0072416
Informations de publication
Date de publication:
Jan 2023
Jan 2023
Historique:
received:
11
10
2022
revised:
15
11
2022
accepted:
16
11
2022
pubmed:
11
12
2022
medline:
14
1
2023
entrez:
10
12
2022
Statut:
ppublish
Résumé
Lung cancer is the leading cause of cancer death in France and worldwide (20 % of cancer deaths). This mortality is partly linked to an overrepresentation of metastatic stages at diagnosis (approximately 55 % of lung cancers at diagnosis). Low-dose chest CT in a target population to detect early forms accessible to radical treatment has been evaluated through multiple randomized trials (NLST, NELSON, MILD, DANTE…). These trials demonstrated a reduction in lung cancer specific mortality. The current problem is to integrate a CT screening policy CT at a national level, which should be both efficient and cost-effective, while presenting the least harms for the eligible population. Finally, it is necessary to optimize the participation of the eligible population and particularly in the most deprived areas and ensure the proper implementation of smoking cessation measures.
Identifiants
pubmed: 36496261
pii: S0007-4551(22)00427-1
doi: 10.1016/j.bulcan.2022.11.006
pii:
doi:
Types de publication
English Abstract
Journal Article
Review
Langues
fre
Sous-ensembles de citation
IM
Pagination
42-54Informations de copyright
Copyright © 2022 Société Française du Cancer. Published by Elsevier Masson SAS. All rights reserved.